Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Caron

Showing results (51-60 of 247) with videos related to

Pageof 25
Sort By:
The Cochrane Database of Systematic Reviews|March 19, 2010
Different anthracycline derivates for reducing cardiotoxicity in cancer patientsElvira C van Dalen, Erna Mc Michiels, Huib N Caron, et al.
The Cochrane Database of Systematic Reviews|June 17, 2011
Cardioprotective interventions for cancer patients receiving anthracyclinesElvira C van Dalen, Huib N Caron, Heather O Dickinson, et al.
The Cochrane Database of Systematic Reviews|January 21, 2011
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancerElvira C van Dalen, Martine F Raphaël, Huib N Caron, et al.
The Cochrane Database of Systematic Reviews|May 14, 2010
Different anthracycline derivates for reducing cardiotoxicity in cancer patientsElvira C van Dalen, Erna Mc Michiels, Huib N Caron, et al.
Genes, Chromosomes & Cancer|January 31, 2003
Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastomaJan J Molenaar, Peter van Sluis, Kathy Boon, et al.
The Cochrane Database of Systematic Reviews|January 23, 2009
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancerElvira C van Dalen, Martine F Raphaël, Huib N Caron, et al.
Surgical Forum|January 1, 1977
Significance of mixed venous oxygen reserve in traumatic shockK K Kazarian, P Sharma, N Caron, et al.
The Cochrane Database of Systematic Reviews|January 28, 2005
Cardioprotective interventions for cancer patients receiving anthracyclinesE C van Dalen, H N Caron, H O Dickinson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expressionFieke Lamers, Linda Schild, Jan Koster, et al.
The Cochrane Database of Systematic Reviews|September 5, 2014
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancerElvira C van Dalen, Martine F Raphaël, Huib N Caron, et al.
Pageof 25

Showing results (51-60 of 247) with videos related to

Sort By:
Pageof 25
The Cochrane Database of Systematic Reviews|March 19, 2010
Different anthracycline derivates for reducing cardiotoxicity in cancer patientsElvira C van Dalen, Erna Mc Michiels, Huib N Caron, et al.
The Cochrane Database of Systematic Reviews|June 17, 2011
Cardioprotective interventions for cancer patients receiving anthracyclinesElvira C van Dalen, Huib N Caron, Heather O Dickinson, et al.
The Cochrane Database of Systematic Reviews|January 21, 2011
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancerElvira C van Dalen, Martine F Raphaël, Huib N Caron, et al.
The Cochrane Database of Systematic Reviews|May 14, 2010
Different anthracycline derivates for reducing cardiotoxicity in cancer patientsElvira C van Dalen, Erna Mc Michiels, Huib N Caron, et al.
Genes, Chromosomes & Cancer|January 31, 2003
Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastomaJan J Molenaar, Peter van Sluis, Kathy Boon, et al.
The Cochrane Database of Systematic Reviews|January 23, 2009
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancerElvira C van Dalen, Martine F Raphaël, Huib N Caron, et al.
Surgical Forum|January 1, 1977
Significance of mixed venous oxygen reserve in traumatic shockK K Kazarian, P Sharma, N Caron, et al.
The Cochrane Database of Systematic Reviews|January 28, 2005
Cardioprotective interventions for cancer patients receiving anthracyclinesE C van Dalen, H N Caron, H O Dickinson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expressionFieke Lamers, Linda Schild, Jan Koster, et al.
The Cochrane Database of Systematic Reviews|September 5, 2014
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancerElvira C van Dalen, Martine F Raphaël, Huib N Caron, et al.
Pageof 25